Document is current
Any future updates will be listed below
-
Authors
Stahl-Pehe, Anna https://orcid.org/0000-0002-5281-6023
Bächle, Christina https://orcid.org/0000-0003-1262-7591
Bódis, Kálmán https://orcid.org/0000-0002-6248-1554
Zaharia, Oana-Patricia https://orcid.org/0000-0002-5738-9585
Lange, Karin https://orcid.org/0000-0002-3636-2025
Holl, Reinhard W. https://orcid.org/0000-0003-1395-4842
Roden, Michael https://orcid.org/0000-0001-8200-6382
Rosenbauer, Joachim https://orcid.org/0000-0002-6086-2230
,
Roden, M.
Al-Hasani, H.
Belgardt, B
Bönhof, GJ.
Burkart, V
Buyken, A. E.
Geerling, G.
Herder, C.
Icks, A.
Jandeleit-Dahm, K.
Kotzka, J.
Kuß, O.
Lammert, E.
Rathmann, W.
Schrauwen-Hinderling, V. B.
Szendroedi, J.
Trenkamp, S.
Wagner, R.
-
Funding
Funding for this research was provided by:
Deutsches Diabetes-Zentrum (DDZ)
- License Information
-
More Information
Article History
Received: 22 November 2022
Accepted: 8 February 2023
First Online: 19 February 2023
Declarations
:
: The study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the ethics committee of the University of Düsseldorf (reference numbers: 3254 and 4508).
: Not applicable.
: MR received personal fees from Eli Lilly, Novo Nordisk, and Target RWE and investigator-initiated research support from Boehringer-Ingelheim, Nutricia/Danone and Sanofi-Aventis. No other potential conflicts of interest relevant to this article were reported.
